Is a complete NAGE research report available?

No complete published report is available for Niagen Bioscience, Inc. (NAGE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · USD

$2.54

+0.04 (+1.6%)· Recorded snapshot

Market cap	201.4M
Revenue (ttm)	129.1M
Net income (ttm)	16M
EPS (ttm)	$0.19
Shares out	79.3M
P/E (trailing)	13.4x
P/E (forward)	38.1x
Volume	297,031
Beta	2.02

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ADM	Archer-Daniels-Midland Company	37.3B	21.2x	0.5x	5.0%	+1.8%	+28.5%	Redukuj
BF.B	Brown-Forman Corporation Class B	12.7B	17.9x	3.3x	14.3%	+1.6%	+0.4%	Kupuj
CAG	Conagra Brands, Inc.	6.6B	—	0.6x	9.2%	+0.2%	-18.9%	Zdecydowanie kupuj

Metric	Value
Amount currency	USD
CIK code	0001386570
Company name	Niagen Bioscience, Inc.
Country	United States
Country code	US
CUSIP number	171077407
Earnings date	2026-11-04
Earnings time	amc
Employees	117
Employees change	13
Employees growth	12.5%
Enterprise value	$137.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1999
In index	RUSSELL2000
Industry	Packaged Foods
Is primary listing	Yes
Is SPAC	No
ISIN number	US1710774076
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2016-04-13
Last stock split type	Reverse
Market cap	$201.4M
Market cap category	Micro-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$2.54
Price currency	USD
Sector	Consumer Staples
Stock price date	2026-10-28
Symbol	NAGE
U.S. state	California
Website	https://www.niagenbioscience.com

Metric

Value

Amount currency

USD

CIK code

0001386570

Company name

Niagen Bioscience, Inc.

Country

United States

Country code

CUSIP number

171077407

Earnings date

2026-11-04

Earnings time

amc

Employees

117

Employees change

Employees growth

12.5%

Enterprise value

$137.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1999

In index

RUSSELL2000

Industry

Packaged Foods

Is primary listing

Yes

Is SPAC

ISIN number

US1710774076

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split date

2016-04-13

Last stock split type

Reverse

Market cap

$201.4M

Market cap category

Micro-Cap

Next earnings date

2026-11-04

Options

Yes

Price

$2.54

Price currency

USD

Sector

Consumer Staples

Stock price date

2026-10-28

Symbol

NAGE

U.S. state

California

Website

https://www.niagenbioscience.com

Metric	Value
Adjusted P/E ratio	22.39x
Average P/E ratio (3Y)	54.69x
Earnings yield	7.49%
EV/Earnings	8.48x
EV/EBIT	15.74x
EV/EBITDA	14.13x
EV/FCF	23.89x
EV/Sales	1.05x
FCF / EV yield	4.19%
FCF yield	2.84%
Forward EV/Sales	0.95x
Forward P/E	38.12x
Forward P/S	1.4x
Graham number	2.11309
Graham upside	-16.15%
Industry forward P/E	12.41x
Industry P/E	68.48x
P/B ratio	2.4x
P/E ratio	13.36x
P/FCF ratio	35.22x
P/OCF ratio	33.59x
P/S ratio	1.55x
Price / tangible book value	2.59x
Price/EBITDA ratio	20.83x
Sector forward P/E	21.33x
Sector P/E	28.29x

Metric

Value

Adjusted P/E ratio

22.39x

Average P/E ratio (3Y)

54.69x

Earnings yield

7.49%

EV/Earnings

8.48x

EV/EBIT

15.74x

EV/EBITDA

14.13x

EV/FCF

23.89x

EV/Sales

1.05x

FCF / EV yield

4.19%

FCF yield

2.84%

Forward EV/Sales

0.95x

Forward P/E

38.12x

Forward P/S

1.4x

Graham number

2.11309

Graham upside

-16.15%

Industry forward P/E

12.41x

Industry P/E

68.48x

P/B ratio

2.4x

P/E ratio

13.36x

P/FCF ratio

35.22x

P/OCF ratio

33.59x

P/S ratio

1.55x

Price / tangible book value

2.59x

Price/EBITDA ratio

20.83x

Sector forward P/E

21.33x

Sector P/E

28.29x

Metric	Value
EBIT margin	6.67%
EBITDA margin	7.43%
Effective tax rate	6.09%
FCF margin	4.4%
Gross margin	64.24%
Operating margin	6.67%
Pretax margin	13.19%
Profit margin	12.39%
Profit per employee	$136,675
Profitable quarters	8
Profitable years	2
Revenue per employee	$1.1M
ROA	5.44%
ROA (5Y)	-8.87%
ROCE	9.41%
ROE	21.8%
ROE (5Y)	-26.69%
ROIC	44%
ROIC (5Y)	-94.24%
SBC / revenue	5.38%
Tax / revenue	0.8%

Metric

Value

EBIT margin

6.67%

EBITDA margin

7.43%

Effective tax rate

6.09%

FCF margin

4.4%

Gross margin

64.24%

Operating margin

6.67%

Pretax margin

13.19%

Profit margin

12.39%

Profit per employee

$136,675

Profitable quarters

Profitable years

Revenue per employee

$1.1M

ROA

5.44%

ROA (5Y)

-8.87%

ROCE

9.41%

ROE

21.8%

ROE (5Y)

-26.69%

ROIC

44%

ROIC (5Y)

-94.24%

SBC / revenue

5.38%

Tax / revenue

0.8%

Metric	Value
EPS growth	-11.65%
EPS growth (Q)	-75%
EPS growth (QoQ)	-85.71%
EPS growth years	4
FCF growth	-72.9%
FCF growth (Q)	140.63%
FCF growth 3Y	50.07%
Gross profit growth	12.07%
Gross profit growth (Q)	-4.51%
Gross profit growth 3Y	19.91%
Gross profit growth 5Y	16.94%
Net income growth	-9.8%
Net income growth (Q)	-73.32%
Net income growth (QoQ)	-84.76%
Net income growth years	4
OCF growth	-71.95%
OCF growth (Q)	121.76%
OCF growth 3Y	43.72%
Operating income growth	-48.32%
Operating income growth (Q)	-78.02%
Revenue growth	10.99%
Revenue growth (Q)	-4.28%
Revenue growth (QoQ)	-5.37%
Revenue growth 10Y	18.36%
Revenue growth 3Y	16.84%
Revenue growth 5Y	15.79%
Revenue growth years	8

Metric

Value

EPS growth

-11.65%

EPS growth (Q)

-75%

EPS growth (QoQ)

-85.71%

EPS growth years

FCF growth

-72.9%

FCF growth (Q)

140.63%

FCF growth 3Y

50.07%

Gross profit growth

12.07%

Gross profit growth (Q)

-4.51%

Gross profit growth 3Y

19.91%

Gross profit growth 5Y

16.94%

Net income growth

-9.8%

Net income growth (Q)

-73.32%

Net income growth (QoQ)

-84.76%

Net income growth years

OCF growth

-71.95%

OCF growth (Q)

121.76%

OCF growth 3Y

43.72%

Operating income growth

-48.32%

Operating income growth (Q)

-78.02%

Revenue growth

10.99%

Revenue growth (Q)

-4.28%

Revenue growth (QoQ)

-5.37%

Revenue growth 10Y

18.36%

Revenue growth 3Y

16.84%

Revenue growth 5Y

15.79%

Revenue growth years

Metric	Value
Capital expenditures	$-275,000
Depreciation and amortization	$976,000
EBIT	$8.6M
EBITDA	$9.6M
EPS	$0.19
FCF per share	$0.07
Financing cash flow	$-4.7M
Free cash flow	$5.7M
Free cash flow minus SBC	$-1.3M
Gross profit	$82.9M
Income taxes	$1M
Investing cash flow	$5M
Net borrowing	$-6,000
Net cash flow	$6.3M
Net income	$16M
Operating cash flow minus SBC	$-994,000
Operating income	$8.6M
Revenue	$129.1M
Stock-based compensation	$6.9M

Metric

Value

Capital expenditures

$-275,000

Depreciation and amortization

$976,000

EBIT

$8.6M

EBITDA

$9.6M

EPS

$0.19

FCF per share

$0.07

Financing cash flow

$-4.7M

Free cash flow

$5.7M

Free cash flow minus SBC

$-1.3M

Gross profit

$82.9M

Income taxes

$1M

Investing cash flow

$5M

Net borrowing

$-6,000

Net cash flow

$6.3M

Net income

$16M

Operating cash flow minus SBC

$-994,000

Operating income

$8.6M

Revenue

$129.1M

Stock-based compensation

$6.9M

Metric	Value
Altman Z-Score	13.6
Book value per share	$1.04
Debt / EBITDA	0.21
Debt / equity	0.03
Debt / FCF	0.41
Long-term assets	$8.8M
Long-term liabilities	$9M
Net cash (debt)	$64.3M
Net cash / market cap	32.16%
Net cash growth	12.68%
Net debt / EBITDA	-6.7
Net debt / equity	-0.78
Net debt / FCF	-11.33
Piotroski F-Score	5
Property, plant and equipment	$3.1M
Shareholders' equity	$82.5M
Tangible book value	$77.2M
Tangible book value per share	$0.98
Total assets	$106.6M
Total cash	$66.6M
Total debt	$2.3M
Total liabilities	$24.1M
WACC	15.17%

Metric

Value

Altman Z-Score

13.6

Book value per share

$1.04

Debt / EBITDA

0.21

Debt / equity

0.03

Debt / FCF

0.41

Long-term assets

$8.8M

Long-term liabilities

$9M

Net cash (debt)

$64.3M

Net cash / market cap

32.16%

Net cash growth

12.68%

Net debt / EBITDA

-6.7

Net debt / equity

-0.78

Net debt / FCF

-11.33

Piotroski F-Score

Property, plant and equipment

$3.1M

Shareholders' equity

$82.5M

Tangible book value

$77.2M

Tangible book value per share

$0.98

Total assets

$106.6M

Total cash

$66.6M

Total debt

$2.3M

Total liabilities

$24.1M

WACC

15.17%

Metric	Value
Asset turnover	1.3
Current assets	$97.8M
Current liabilities	$15.1M
Current ratio	6.5
Inventory turnover	2.63
Net working capital	$17.1M
Quick ratio	4.99
Working capital	$82.7M
Working capital turnover	1.76

Metric

Value

Asset turnover

1.3

Current assets

$97.8M

Current liabilities

$15.1M

Current ratio

6.5

Inventory turnover

2.63

Net working capital

$17.1M

Quick ratio

4.99

Working capital

$82.7M

Working capital turnover

1.76

Metric	Value
Buyback yield / dilution	-2.25%
Dividend yield	0%
Shareholder yield	-2.25%

Metric

Value

Buyback yield / dilution

-2.25%

Dividend yield

Shareholder yield

-2.25%

Metric	Value
10Y price change	-9.43%
10Y return CAGR	-0.99%
10Y total return	-9.43%
150-day SMA	$3.50
15Y price change	0.99%
15Y return CAGR	0.07%
15Y total return	0.99%
1D price change	1.6%
1M price change	-16.56%
1M total return	-16.56%
1W price change	1.39%
1W total return	1.39%
1Y price change	-66.51%
1Y return CAGR	-66.54%
1Y total return	-66.51%
20-day SMA	$2.58
200-day SMA	$3.96
3M price change	-21.21%
3M total return	-21.21%
3Y price change	92.8%
3Y return CAGR	24.46%
3Y total return	92.8%
50-day SMA	$2.89
50-day SMA vs 200-day SMA	50under200
52-week high	$7.95
52-week high date	2025-11-05
52-week low	$2.39
52-week low date	2026-10-26
5Y price change	-58.48%
5Y return CAGR	-16.12%
5Y total return	-58.48%
6M price change	-48.69%
6M total return	-48.69%
All-time high	$23.66
All-time high date	2021-02-25
All-time low	$0.33
All-time low date	2009-08-03
Average true range (ATR)	$0.09
Average volume	592.1K
Beta (1Y)	0.98
Beta (2Y)	0.79
Beta (5Y)	2.02
Change from 52-week high	-68.05%
Change from 52-week low	6.5%
Change from all-time high	-89.24%
Change from all-time low	671.21%
Change from open	2.42%
Day's gap	-0.8%
Dollar volume	$754,459
High price	$2.55
Low price	$2.48
Monthly RSI	38.7
Open price	$2.48
Position in 52-week range	92.31%
Premarket change	0.58%
Premarket close	$2.50
Premarket price	$2.51
Premarket volume	691
Previous close	$2.50
Price vs 150-day SMA	-27.26%
Price vs 20-day SMA	-1.43%
Price vs 200-day SMA	-35.68%
Price vs 50-day SMA	-11.91%
Relative volume	0.5
RSI	40.99
Sharpe ratio	-2.19
Sharpe ratio (3Y)	0.59
Sharpe ratio (5Y)	0.06
Sortino ratio	-2.52
Sortino ratio (3Y)	1.19
Sortino ratio (5Y)	0.19
Volume	297K
Weekly RSI	28.18
YTD price change	-59.98%
YTD total return	-59.98%

Metric

Value

10Y price change

-9.43%

10Y return CAGR

-0.99%

10Y total return

-9.43%

150-day SMA

$3.50

15Y price change

0.99%

15Y return CAGR

0.07%

15Y total return

0.99%

1D price change

1.6%

1M price change

-16.56%

1M total return

-16.56%

1W price change

1.39%

1W total return

1.39%

1Y price change

-66.51%

1Y return CAGR

-66.54%

1Y total return

-66.51%

20-day SMA

$2.58

200-day SMA

$3.96

3M price change

-21.21%

3M total return

-21.21%

3Y price change

92.8%

3Y return CAGR

24.46%

3Y total return

92.8%

50-day SMA

$2.89

50-day SMA vs 200-day SMA

50under200

52-week high

$7.95

52-week high date

2025-11-05

52-week low

$2.39

52-week low date

2026-10-26

5Y price change

-58.48%

5Y return CAGR

-16.12%

5Y total return

-58.48%

6M price change

-48.69%

6M total return

-48.69%

All-time high

$23.66

All-time high date

2021-02-25

All-time low

$0.33

All-time low date

2009-08-03

Average true range (ATR)

$0.09

Average volume

592.1K

Beta (1Y)

0.98

Beta (2Y)

0.79

Beta (5Y)

2.02

Change from 52-week high

-68.05%

Change from 52-week low

6.5%

Change from all-time high

-89.24%

Change from all-time low

671.21%

Change from open

2.42%

Day's gap

-0.8%

Dollar volume

$754,459

High price

$2.55

Low price

$2.48

Monthly RSI

38.7

Open price

$2.48

Position in 52-week range

92.31%

Premarket change

0.58%

Premarket close

$2.50

Premarket price

$2.51

Premarket volume

691

Previous close

$2.50

Price vs 150-day SMA

-27.26%

Price vs 20-day SMA

-1.43%

Price vs 200-day SMA

-35.68%

Price vs 50-day SMA

-11.91%

Relative volume

0.5

RSI

40.99

Sharpe ratio

-2.19

Sharpe ratio (3Y)

0.59

Sharpe ratio (5Y)

0.06

Sortino ratio

-2.52

Sortino ratio (3Y)

1.19

Sortino ratio (5Y)

0.19

Volume

297K

Weekly RSI

28.18

YTD price change

-59.98%

YTD total return

-59.98%

Metric	Value
Float	59.1M
Float percentage	74.5%
Shares change (QoQ)	-2.44%
Shares change (YoY)	2.25%
Shares held by insiders	25.02%
Shares held by institutions	45.23%
Shares outstanding	79.3M
Short % of float	6.56%
Short % of shares	4.89%
Short ratio	10.1 days

Metric

Value

Float

59.1M

Float percentage

74.5%

Shares change (QoQ)

-2.44%

Shares change (YoY)

2.25%

Shares held by insiders

25.02%

Shares held by institutions

45.23%

Shares outstanding

79.3M

Short % of float

6.56%

Short % of shares

4.89%

Short ratio

10.1 days

Niagen Bioscience, Inc. (NAGE)

Price

Financial snapshot

Fair-value bridge

Latest news · NAGE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NAGE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NAGE

Frequently asked questions